Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. (Q48208372)

9 February 2018

title

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. (English)

1 reference

9 February 2018

0 references

Yang SC

1

1 reference

9 February 2018

Lu LF

2

1 reference

9 February 2018

Cai Y

3

1 reference

9 February 2018

Zhu JB

4

1 reference

9 February 2018

Liang BW

5

1 reference

9 February 2018

Yang CZ

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

9 February 2018

Journal of Controlled Release

published in

1 reference

9 February 2018

volume

59

1 reference

9 February 2018

page(s)

299-307

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

The structural basis of camptothecin interactions with human serum albumin: impact on drug stability

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Determination of camptothecin in biological fluids using reversed-phase high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

High-performance liquid chromatographic analysis of the antitumour drug camptothecin and its lactone ring-opened form in rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Enhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Differential interactions of camptothecin lactone and carboxylate forms with human blood components.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Blood-brain-barrier transport of lipid microspheres containing clinprost, a prostaglandin I2 analogue.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900007-3

7 January 2021

10.1016/S0168-3659(99)00007-3

Identifiers

DOI

1 reference

9 February 2018

release_axnookmrmzbvxiaylb7nrmujje

Fatcat ID

0 references

PubMed ID

10332062

1 reference

9 February 2018